【Synergy Medical】Announcement of Board Approval of Q1 2026 Consolidated Financial Report

1. Date of submission to or resolution by the board of directors: 2026/05/06 2. Date of approval by the audit committee: 2026/05/06 3. Reporting period for financial report or annual self-reported financial information (YYYY/MM/DD~YYYY/MM/DD): 2026/01/01~2026/03/31 4. Cumulative operating revenue from January 1 to the end of this period (in thousands of NTD): 1,160,484 5. Cumulative operating gross profit (loss) from January 1 to the end of this period (in thousands of NTD): 268,404 6. Cumulative operating income (loss) from January 1 to the end of this period (in thousands of NTD): 77,158 7. Cumulative net profit before tax (loss) from January 1 to the end of this period (in thousands of NTD): 51,273 8. Cumulative net profit (loss) for this period from January 1 to the end of this period (in thousands of NTD): 36,246 9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands of NTD): 26,195 10. Cumulative basic earnings per share (loss) from January 1 to the end of this period (in NTD): 0.13 11. Total assets at the end of the period (in thousands of NTD): 15,956,285 12. Total liabilities at the end of the period (in thousands of NTD): 8,078,503 13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 7,447,429 14. Other matters that should be specified: None.